National Institute of Allergy & Infectious Diseases | Financial Times

Accessibility help Skip to navigation Skip to content Skip to footer

Coronavirus business update Get 30 days’ complimentary access to our Coronavirus Business Update newsletter 30 days complimentary

Promotion for Financial Times' Coronavirus Business Update newsletter explaining the Coronavirus' impact on the global financial markets

Get the newsletter now

Friday, 22 May, 2020

Coronavirus: free to read
Scientists vs politicians: the reality check for ‘warp speed’ vaccine research
Hollywood-style messages from politicians about beating the pandemic downplay the technical complexity
Wednesday, 29 April, 2020

Coronavirus
Fauci praises remdesivir after data show it speeds recovery
US-run trial of Gilead coronavirus therapy demonstrates ‘significant positive effect’
Monday, 24 July, 2017

Medical science
New vaccine enters the battle against Aids
Thousands volunteer for tests of experimental ‘Ad26 mosaic’
Tuesday, 18 April, 2017

Special ReportFT Health: Vaccines
Science looks to create the right genetic recipe
Proponents say vaccines made of RNA and DNA will prove safer and cheaper
Friday, 12 February, 2016

Pharmaceuticals sector
Rush to develop Zika vaccine
Industry response contrasts with slow reaction to previous disease outbreaks, including Ebola
Sunday, 22 January, 2012

World
Pause in bird flu research amid safety fears
Infectious Diseases chief calls for international debate
Sunday, 16 August, 2009

World
Poor will suffer most from swine flu
Thursday, 27 October, 2005

Work & Careers
Cracks in the laboratory’s glass ceiling
Monday, 30 May, 2005

Work & Careers
Worth watching
Promoted Content